Evidence map›Paper›PMID 25407936›Full record

ArticlePigment cell & melanoma research2015

Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells.

Marie R Webster, Mai Xu, Kathryn A Kinzler, Amanpreet Kaur, Jessica Appleton, Michael P O'Connell, Katie Marchbank, Alexander Valiga, Vanessa M Dang, Michela Perego and 13 more

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Molecular Analysis of Murine KitJID innovations : skin science from molecules to population health · 2024
    Article
  11. Cellular senescence: Neither irreversible nor reversible.The Journal of experimental medicine · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Marie R WebsterThe Wistar Institute, Philadelphia, PA, USA.
Mai Xu
Kathryn A Kinzler
Amanpreet Kaur
Jessica Appleton
Michael P O'Connell
Katie Marchbank
Alexander Valiga
Vanessa M Dang
Michela Perego
Gao Zhang
Ana Slipicevic
Frederick Keeney
Elin Lehrmann
William Wood
Kevin G Becker
Andrew V Kossenkov
Dennie T Frederick
Keith T Flaherty
Xiaowei Xu
Meenhard Herlyn
Maureen E Murphy
Ashani T Weeraratna

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9M
Targeting the MAP and PI3 Kinase Pathways in MelanomaP01CA114046 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2008 to 2023
$37.1M
Analysis of complex biological systems by microarray based gene expressionZICAG000616 · NIA · NATIONAL INSTITUTE ON AGING · PI DE, SUPRIYO · 2009 to 2025
$15.5M
TRAINING PROGRAM IN BASIC CANCER RESEARCHT32CA009171 · NCI · WISTAR INSTITUTE · PI Alessandro Gardini · 1985 to 2026
$15.3M
Targeted Combination Therapy for MelanomaP50CA174523 · NCI · WISTAR INSTITUTE · PI HERLYN, MEENHARD F · 2014 to 2018
$11.1M
The ARF Tumor SuppressorR01CA139319 · NCI · WISTAR INSTITUTE · PI MURPHY, MAUREEN E. · 2010 to 2019
$3.9M
Promotion of tumor invasion and pseudosenescence by the aging microenvironmentR01CA174746 · NCI · WISTAR INSTITUTE · PI WEERARATNA, ASHANI T · 2014 to 2018
$2.1M
Intramural NIH HHSNCI NIH HHS P01 CA114046NCI NIH HHS P01 CA 114046-06NCI NIH HHS P30 CA010815NCI NIH HHS P50 CA174523NCI NIH HHS R01 CA139319NCI NIH HHS R01 CA174746NCI NIH HHS R01 CA174746-01NCI NIH HHS T32 CA009171NCI NIH HHS T32 CA 9171-36
6 · The paper itself

Abstract

We have previously shown that Wnt5A drives invasion in melanoma. We have also shown that Wnt5A promotes resistance to therapy designed to target the BRAF(V600E) mutation in melanoma. Here, we show that melanomas characterized by high levels of Wnt5A respond to therapeutic stress by increasing p21 and expressing classical markers of senescence, including positivity for senescence-associated β-galactosidase (SA-β-gal), senescence-associated heterochromatic foci (SAHF), H3K9Me chromatin marks, and PML bodies. We find that despite this, these cells retain their ability to migrate and invade. Further, despite the expression of classic markers of senescence such as SA-β-gal and SAHF, these Wnt5A-high cells are able to colonize the lungs in in vivo tail vein colony-forming assays. This clearly underscores the fact that these markers do not indicate true senescence in these cells, but instead an adaptive stress response that allows the cells to evade therapy and invade. Notably, silencing Wnt5A reduces expression of these markers and decreases invasiveness. The combined data point to Wnt5A as a master regulator of an adaptive stress response in melanoma, which may contribute to therapy resistance.

Indexed as

Cellular SenescenceStress, PhysiologicalAnimalsBiomarkers, TumorClone CellsCyclin-Dependent Kinase Inhibitor p21FemaleHumansMelanomaMice, NudeNeoplasm InvasivenessPhenotypeProto-Oncogene ProteinsSkin NeoplasmsTumor Stem Cell AssayWnt-5a ProteinBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p21Proto-Oncogene ProteinsWnt-5a ProteinWNT5A protein, humanWnt ProteinsBRAFmetastasissenescencetherapy resistanceWnt5A

Identifiers

PMID25407936
PMCPMC4333017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.